Clinical Trials Related to Graft Versus Host Disease

Related studies linked through entity extraction aliases.

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver Transplantation

Status: UNKNOWN
Phase: NA

High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant

Status: COMPLETED
Phase: PHASE2

Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant

Status: TERMINATED
Phase: NA

A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD

Status: TERMINATED
Phase: PHASE2/PHASE3

Efficacy and Safety of Nilotinib in Patients With a Chronic Disease of the Graft Against the Host

Status: COMPLETED
Phase: PHASE2

Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients

Status: TERMINATED
Phase: PHASE2

Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease

Status: COMPLETED
Phase: PHASE1

T Lymphocytes (LT) Expressing iCASP9 and ΔCD19 in Allogeneic Haematopoietic Transplantation.

Status: TERMINATED
Phase: PHASE1/PHASE2

Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD

Status: COMPLETED
Phase: PHASE1/PHASE2

Early Detection of Mucosal Abnormalities in Graft-versus-host Disease

Status: COMPLETED
Phase: NA

Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)

Status: COMPLETED
Phase: PHASE2

Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling Donor

Status: COMPLETED
Phase: PHASE4

Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention

Status: COMPLETED
Phase: PHASE2

Donor Regulatory T Cells in Treating Patients With Visceral Acute Graft-versus-Host Disease After Stem Cell Transplant

Status: WITHDRAWN
Phase: PHASE1

Transdermal Patch to Monitor Inflammatory Biomarkers of GVHD

Status: COMPLETED
Phase: NA

Irradiated Blood Versus Non Irradiated Blood Transfusions in Craniosynostosis Repair

Status: COMPLETED
Phase: NA

Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT

Status: COMPLETED
Phase: N/A

CINC424A2X01B Rollover Protocol

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE4

BMT Autologous MSCs for GvHD

Status: COMPLETED
Phase: PHASE1